1036 related articles for article (PubMed ID: 28806822)
1. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
[No Abstract] [Full Text] [Related]
2. The Diagnosis and Treatment of Multiple Myeloma.
Gerecke C; Fuhrmann S; Strifler S; Schmidt-Hieber M; Einsele H; Knop S
Dtsch Arztebl Int; 2016 Jul; 113(27-28):470-6. PubMed ID: 27476706
[TBL] [Abstract][Full Text] [Related]
3. [Multiple myeloma. Diagnosis and therapy].
Goldschmidt H; Cremer FW; Möhler TM; Ho AD
Internist (Berl); 2003 May; 44(5):599-600, 603-16; quiz 617-8. PubMed ID: 12966788
[TBL] [Abstract][Full Text] [Related]
4. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
Kyle RA
Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal gammopathy--multiple myeloma].
Dietzfelbinger H
MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
[TBL] [Abstract][Full Text] [Related]
6. Treatment of multiple myeloma.
San Miguel JF; Bladé Creixenti J; García-Sanz R
Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
[TBL] [Abstract][Full Text] [Related]
7. Multiple Myeloma - Current Standards in Surgical Treatment.
Kehrer M; Koob S; Kehrer A; Wirtz DC; Schmolders J
Z Orthop Unfall; 2019 Apr; 157(2):164-172. PubMed ID: 30064148
[TBL] [Abstract][Full Text] [Related]
8. [Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma].
Adam Z; Bednarík J; Neubauer J; Chaloupka R; Fojtík Z; Vanícek J; Pour L; Cermákova Z; Scudla V; Maisnar V; Straub J; Schützová M; Gregora E; Weinreb M; Stuchlíková K; Stanícek J; Hájek R; Krejcí M; Vorlícek J;
Vnitr Lek; 2006 Nov; 52 Suppl 2():9, 11-31. PubMed ID: 18175427
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: diagnosis and treatment.
Nau KC; Lewis WD
Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
[TBL] [Abstract][Full Text] [Related]
10. A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.
Paiva B; Vídriales MB; Rosiñol L; Martínez-López J; Mateos MV; Ocio EM; Montalbán MÁ; Cordón L; Gutiérrez NC; Corchete L; Oriol A; Terol MJ; Echeveste MA; De Paz R; De Arriba F; Palomera L; de la Rubia J; Díaz-Mediavilla J; Granell M; Gorosquieta A; Alegre A; Orfao A; Lahuerta JJ; Bladé J; San Miguel JF;
Leukemia; 2013 Oct; 27(10):2056-61. PubMed ID: 23743858
[TBL] [Abstract][Full Text] [Related]
11. Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back.
Bianchi G; Anderson KC
CA Cancer J Clin; 2014; 64(6):422-44. PubMed ID: 25266555
[TBL] [Abstract][Full Text] [Related]
12. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and therapy of multiple myeloma: current aspects].
Betticher DC; Cerny T; Fey MF
Schweiz Med Wochenschr; 1995 Mar; 125(11):541-51. PubMed ID: 7899848
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy and smoldering multiple myeloma: diagnosis, staging, prognosis, management.
Hillengass J; Moehler T; Hundemer M
Recent Results Cancer Res; 2011; 183():113-31. PubMed ID: 21509683
[TBL] [Abstract][Full Text] [Related]
15. [Current and future approaches to therapy for multiple myeloma].
Nara N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):9-15. PubMed ID: 7826084
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma.
Bladé J; Cibeira MT; Fernández de Larrea C; Rosiñol L
Ann Oncol; 2010 Oct; 21 Suppl 7():vii313-9. PubMed ID: 20943635
[TBL] [Abstract][Full Text] [Related]
17. BrdU incorporation in multiparameter flow cytometry: A new cell cycle assessment approach in multiple myeloma.
Requirand G; Robert N; Boireau S; Vincent L; Seckinger A; Bouhya S; Ceballos P; Cartron G; Hose D; Klein B; Moreaux J
Cytometry B Clin Cytom; 2019 May; 96(3):209-214. PubMed ID: 30417559
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.
Martino M; Morabito F
Expert Opin Biol Ther; 2015 Feb; 15(2):149-54. PubMed ID: 25435056
[TBL] [Abstract][Full Text] [Related]
19. Bone Tumors: Multiple Myeloma.
Kane SF
FP Essent; 2020 Jun; 493():30-35. PubMed ID: 32573185
[TBL] [Abstract][Full Text] [Related]
20. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
